Evaluating Human KIR B Haplotype in Mice
Corresponding Organization : University of Southampton
Other organizations : Centre Val de Loire, Établissement Français du Sang
Variable analysis
- DNA constructs expressing HLA-C*0102 alone or linked with the T2A self-cleaving peptide and peptide
- Injection of 50 µg DNA plasmid on days 0 and 7 for the B16 model
- Injection of 1x10^6 purified NK cells from 2 weeks vaccinated KIR transgenic (KIR-Tg) mice spleen on days 0 and 14 for the Huh7 model
- Tumor growth in the B16 model
- Tumor growth in the Huh7 model
- KIR transgenic mouse expressing a complete human KIR B haplotype on a C57BL6 background MHC class I–deficient Kb-/- Db-/- were used
- Specific pathogen-free conditions were maintained
- 2.5x10^5 B16F10 cells were injected into the left flank of mice for the B16 model
- 2x10^6 Huh7-C*0102 cells were injected subcutaneously into NSG mice for the Huh7 model
- NK cell purity was > 90% with < 3% CD3+ T cells
- Positive control: Not explicitly mentioned.
- Negative control: Not explicitly mentioned.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!